Keywords: Type 2 diabets prototype, Dana Farber Cancer Institute, Scripps Researdy, Avandia, GlaxoSmithKline, Takeda, Actos

New twist in diabetes drugs could reduce life-threatening side effects

Article | 12 September 2011

Print This

Researchers from Dana-Farber Cancer Institute in Boston and the Scripps Research Institute in Jupiter, Florida, USA, report they have created ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in